Effects of renin-angiotensin system blockers on the risk and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with hypertension
Jinwoo Lee, Seong Jin Jo, Youngjin Cho, Ji Hyun Lee, Il-Young Oh, Jin Joo Park, Young-Seok Cho, Dong-Ju Choi
Korean J Intern Med. 2021;36(Suppl 1):S123-S131. Published online 2021 Feb 10 DOI: https://doi.org/10.3904/kjim.2020.390
Citations to this article as recorded by 
Systematic review and meta-analysis of the clinical outcomes of ACEI/ARB in East-Asian patients with COVID-19
Nancy Xurui Huang, Qi Yuan, Fang Fang, Bryan P. Yan, John E. Sanderson, Masaki Mogi
PLOS ONE.2023; 18(1): e0280280. CrossRef
Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis
Abraham Degarege, Zaeema Naveed, Josiane Kabayundo, David Brett-Major
Pathogens.2022; 11(5): 563. CrossRef
Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
Jordan Loader, Frances C. Taylor, Erik Lampa, Johan Sundström
Journal of the American Heart Association.2022;[Epub] CrossRef
Foe and friend in the COVID-19-associated acute kidney injury: an insight on intrarenal renin-angiotensin system
Chuanming Xu, Yanting Chen, Jun Yu
Acta Biochimica et Biophysica Sinica.2022; 54(1): 1. CrossRef
The effect of renin–angiotensin–aldosterone system inhibitors in patients with hypertension and COVID-19: A meta-analysis of randomized controlled trials and propensity score-matched studies
Kai Zhang, Lanxin Cao, Nanxia Xuan, Tiancha Huang, Baoping Tian, Wei Cui, Gensheng Zhang, Shufang Zhang
Journal of Intensive Medicine.2022; 2(4): 282. CrossRef
The effects of hypertension on the prognosis of coronavirus disease 2019: a systematic review and meta-analysis on the interactions with age and antihypertensive treatment
Alimamy Umaru Kabia, Ping Li, Zhichao Jin, Xiaojie Tan, Yilong Liu, Yuqi Feng, Keyao Yu, Ming Hu, Dongming Jiang, Guangwen Cao
Journal of Hypertension.2022; 40(12): 2323. CrossRef
Pre-Admission Beta-Blocker Therapy and Outcomes of Coronavirus
Disease 2019 (COVID-19): A Systematic Review, Meta-Analysis, and
Meta-Regression
Timotius Ivan Hariyanto, Joshua Edward Hananto, Denny Intan, Andree Kurniawan
Cardiovascular & Hematological Disorders-Drug Targets.2022; 22(2): 104. CrossRef
A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor
Murat Oz, Dietrich Ernst Lorke, Nadine Kabbani
Pharmacology & Therapeutics.2021; 221: 107750. CrossRef
Renin‐Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID‐19
Jordan Loader, Erik Lampa, Stefan Gustafsson, Thomas Cars, Johan Sundström
Journal of the American Heart Association.2021;[Epub] CrossRef
Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19
Tomas Rajtik, Peter Galis, Linda Bartosova, Ludovit Paulis, Eva Goncalvesova, Jan Klimas
International Journal of Molecular Sciences.2021; 22(23): 12800. CrossRef